KWR / Quaker Chemical Corporation - Pemfailan SEC, Laporan Tahunan, Penyata Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUA

Quaker Houghton Second Quarter 2025 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

kwr2025q2ex-992 Quaker Houghton Second Quarter 2025 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2025 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2025 RESULTS •Q2’25 net sales of $483.4 million, an increase of 4% Y/Y •Organic sales volumes increased 2% Y/Y driven by new business wins of approximately 5% •Q2’25 net loss of $66.6 million and loss per diluted

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 31, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 31, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction o

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 18, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 A. Full title of the plan and the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT QUAKER CHEMICAL CORPORATION (Exact Name of Registrant as Specified in Its Charter) Pennsylvania 23-0993790 (State or Other Jurisdiction of I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT QUAKER CHEMICAL CORPORATION (Exact Name of Registrant as Specified in Its Charter) Pennsylvania 23-0993790 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) One Quaker Park, 901 E. Hector Street Conshohocken, Pennsylvania 19428-2380 (Addres

Conflict Minerals Report of Quaker Chemical Corporation for the period of January 1, 202

Conflict Minerals Report of Quaker Chemical Corporation for the period of January 1, 2024 to December 31, 2024 1.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 14, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 7, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Quaker Houghton First Quarter 2025 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

Quaker Houghton First Quarter 2025 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QU

QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2025 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2025 RESULTS •Q1’25 net sales of $442.9 million, net income of $12.9 million and earnings per diluted share of $0.73 •Q1’25 non-GAAP net income of $28.0 million and non-GAAP earnings per diluted share of $1.58 •De

Change in Control Agreement by and between Registrant and Miguel Moreno dated March 1, 2025.*†

EXHIBIT 10.6 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated March 1, 2025 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and MIGUEL MORENO (the “Manager”) W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its su

AG Concert Limited Partnership, an exempted limited partnership organized and existing under the Laws of the Cayman Islands

EXHIBIT 2.1 SHARE PURCHASE AGREEMENT by and among AG III INVESTMENT LIMITED PARTNERSHIP, AG CHORUS LIMITED PARTNERSHIP, AG CONCERT LIMITED PARTNERSHIP, QUAKER CHEMICAL CORPORATION, and QUAKER CHEMICAL CORPORATION TABLE OF CONTENTS SECTION 1 Definitions and Construction. 2 1.1 Definitions. 2 1.2 Construction. 11 1.3 Section and Schedule References. 11 1.4 Headings. 11 1.5 Interpretation. 12 SECTION

Change in Control Agreement by and between Registrant and Renato Carvalho dated March 1, 2025.*†

EXHIBIT 10.2 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated March 1, 2025 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and RENATO CARVALHO (the “Manager”) W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its

Employment Agreement by and between Registrant and Albert Ma dated April 1, 2016.*†^

EXHIBIT 10.3 Labor Contracts Party A's name: Quaker Houghton Investment Management (Shanghai) Co., Ltd Registered address: 7/8th Floor, Building 3, No. 715, Yingshun Road, Qingpu District, Shanghai Main person in charge: Ma Jun Party B's Name: Albert Ma Address: [***] Identification Number: [***] Party A and Party B are in accordance with the Labor Law of the People's Republic of China, the Labor

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 1, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Change in Control Agreement by and between Registrant and Albert Ma dated

EXHIBIT 10.4 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated March 1, 2025 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and ALBERT MA (the “Manager”) W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its subsid

Employment Agreement by and between Registrant and Miguel Moreno dated July 2, 2018.*†^

EXHIBIT 10.5 Uithoorn, 2nd of July 2018 Conc.: permanent contract of employment Dear Mr. Moreno, Referring to our recent discussions we are pleased to offer you employment with Quaker Sales Europe BV. in the position of Senior Director EMEA Metals. The content of your function has been discussed with you in broad outline; herewith you have committed yourself to do all work that can reasonably be a

Employment Agreement by and between Registrant and Renato Carvalho dated January 23, 2012.*†^

EXHIBIT 10.1 EMPLOYMENT CONTRACT This Employment Contract (“Contract”) is entered into by and between the parties identified below (hereinafter referred to jointly as “Parties” and, individually, as “Party”): I. On the one part: (a) HOUGHTON BRASIL LTDA., a limited company duly incorporated and existing in accordance with the laws of Brazil, headquartered in the City of Maua, State of Sao Paulo, a

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 1, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction o

Quaker Houghton Completes its Acquisition of Dipsol Chemicals and Announces its acquisition of Natech, Ltd.

Exhibit 99.1 News Investor Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T.+1.610.832.4087 Media Contact: Melissa McClain Director, Global Communications [email protected] T. +1.610.832.7809 For Release: Immediate Quaker Houghton Completes its Acquisition of Dipsol Chemicals and Announces its acquisition of Natech, Ltd. CONSHOHOCKEN, PA (April 1, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Quaker Houghton Expands Advanced Solutions Portfolio Through its Acquisition of Dipsol Chemicals

Exhibit 99.1 News Investor Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T.+1.610.832.4087 Media Contact: Melissa McClain Director, Global Communications [email protected] T. +1.610.832.7809 For Release: Immediate Quaker Houghton Expands Advanced Solutions Portfolio Through its Acquisition of Dipsol Chemicals CONSHOHOCKEN, PA (March 25, 2025) /PRNew

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 25, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction

Subsidiaries and Affiliates of the Registrant.*

EXHIBIT 21 SUBSIDIARIES AND AFFILIATES OF THE REGISTRANT Name Jurisdiction of Incorporation Percentage of Voting Securities Owned Directly or Indirectly by Quaker * Quaker Houghton Argentina S.

QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS •Q4’24 net sales of $444.1 million, net income of $14.2 million and earnings per diluted share of $0.81 •Q4’24 non-GAAP net income of $23.6 million and non-GAAP earnings per diluted sha

Quaker Houghton Annual Incentive Plan (as amended and restated effective

EXHIBIT 10.31 QUAKER HOUGHTON ANNUAL INCENTIVE PLAN (As Amended and Restated May 8, 2024) WHEREAS, Quaker Chemical Corporation doing business as Quaker Houghton (the “Company”) maintains the Quaker Houghton Annual Incentive Plan (the “Plan”); and WHEREAS, the Company desires to amend and restate the Plan to provide for a pro rata payment upon an involuntary termination and to make certain other ch

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORPORATION

Employment Agreement by and between Quaker Chemical Corporation and Kristin Rokosky, dated January 22, 2025. *†

EXHIBIT 10.26 EMPLOYMENT AGREEMENT January 22, 2025 KRISTIN ROKOSKY [ REDACTED ] [ REDACTED ] The parties to this Employment Agreement (“Agreement”) are Kristin Rokosky (“You” or the “Executive”) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (“Quaker Houghton” or the “Company”). You are hereby appointed as the Company’s SVP and Chief Human Resources Officer (“C

Separation Agreement and General Release by and between Quaker Chemical Corporation and Shane Hostetter, dated June 28, 2024. *†

EXHIBIT 10.19 SEPARATION AGREEMENT AND GENERAL RELEASE Whereas, Shane Hostetter (herein referred to as “Employee”) has been employed by Quaker Houghton (herein referred to as “Employer”) as EVP, Chief Financial Officer; and Whereas, Employee’s employment with Employer is separated effective as of June 28, 2024 (the “Separation Date”) and Employee wants to enter into an agreement whereby the Employ

Change in Control Agreement by and between Quaker Chemical Corporation and Kristin Rokosky, dated January 22, 2025. *†

EXHIBIT 10.27 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated January 22, 2025 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and KRISTIN ROKOSKY (the “Manager”) W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 24, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 24, 2025 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

Insider Trading Policy.

EXHIBIT 19.0 QUAKER HOUGHTON POLICY RELATING TO CONFIDENTIALITY OF INFORMATION AND INSIDER TRADING IN SECURITIES Quaker Houghton (“Quaker Houghton” or the “Company”) has adopted the following Policy relating to trading in Quaker Houghton securities consistent with the legal and ethical responsibilities that we have because of Quaker Houghton’s status as a public company. The Policy applies to all

Quaker Houghton Fourth Quarter and Full Year 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an an

kwr20241231ex-992 Quaker Houghton Fourth Quarter and Full Year 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

Quaker Houghton Compensation Recoupment Policy

Exhibit 97 QUAKER HOUGHTON COMPENSATION RECOUPMENT POLICY Adopted September 20, 2023 Policy The Board of Directors (the “Board”) of Quaker Houghton has adopted this Compensation Recoupment Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities and Exchange Act of 1934, the Securities and Exchange Commission (“SEC”) regulations promulgated thereunder, and applicable New York Stock Exchange (“NYSE”) listing standards.

Separation Agreement and General Release by and between Quaker Chemical Corporation and Melissa Leneis, dated January

EXHIBIT 10.25 SEPARATION AGREEMENT AND GENERAL RELEASE Whereas, Melissa Leneis (herein referred to as "Employee") has been employed by Quaker Chemical Corporation d/b/a Quaker Houghton (herein referred to as "Employer") as Executive Vice President and Chief Human Resources Officer; Whereas, Employee's employment with Employer is separated without Cause as defined in the Employment Agreement dated

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 15, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

Form of Restricted Stock Unit Award Agreement for certain executive officers under Registrant’s 2024 Long-Term Performance Incentive Plan

Exhibit 10.1 RESTRICTED STOCK UNIT AWARD The Compensation and Human Resources Committee (the “Committee”) of the Board of Directors of Quaker Houghton (the “Company”) has approved the award (the “Award”) to ###PARTICIPANTNAME### (the “Grantee”), of ###TOTALAWARDS### Restricted Stock Units (“Target RSUs”) under the Quaker Houghton Long-Term Performance Incentive Plan (the “2024 Plan”), subject to f

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm2431275d3sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 24)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Li

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm2430811d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 23)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Li

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 5, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 5, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdictio

Separation Agreement and General Release by and between Quaker Chemical Corporation and Andrew E. Tometich, dated December 5, 2024

Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE Whereas, Andrew Tometich (herein referred to as “Employee”) has been employed by Quaker Houghton (herein referred to as “Employer”) as Chief Executive Officer and President; and Whereas, Employee’s employment with Employer is separated effective as of November 18, 2024 (the “Separation Date”) and Employee wants to enter into an agreement whereb

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm2430502d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 22)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Li

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 2, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdictio

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm2430141d3sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 21)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Li

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 20)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

Supplemental Confirmation No. 9, dated November 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

EX-99.3 4 tm2429563d1ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 Execution Version SUPPLEMENTAL CONFIRMATION NO. 9 Date: November 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From:  Citibank, N.A. Fax No.: 212-615-8985 Reference Numb

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm2429563d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 19)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Li

Sixth Amended and Restated Supplemental Confirmation No. 2, dated November 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

EX-99.1 2 tm2429563d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Execution Version SIXTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2 Date: November 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 2

Supplemental Confirmation No. 6, dated November 22, 2024, by and among QH Hungary Holdings Limited and Royal Bank of Canada.

EX-99.4 5 tm2429563d1ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 Execution Version SUPPLEMENTAL CONFIRMATION NO. 6 Date: November 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised

Sixth Amended and Restated Supplemental Confirmation No. 1, dated November 22, 2024, by and among QH Hungary Holdings Limited and Royal Bank of Canada.

EX-99.2 3 tm2429563d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Execution Version SIXTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1 Date: November 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Refe

Change in Control Agreement by and between Quaker Chemical Corporation and Joseph A. Berquist, dated November 18, 2024

Exhibit 10.2 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated November 18, 2024 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and Joseph A. Berquist (the “Manager”). W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company

Employment Agreement by and between Quaker Chemical Corporation and Joseph A. Berquist, dated November 18, 2024

Exhibit 10.1   EMPLOYMENT AGREEMENT   November 18, 2024     Joseph A. Berquist XXXXXX   The parties to this Employment Agreement (“Agreement”) are Joseph A. Berquist (“You” or the “Executive”) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (“Quaker Houghton” or the “Company”).   You are hereby appointed as the Company’s Chief Executive Officer and President effe

Quaker Houghton Appoints Joseph Berquist as CEO and President

Exhibit 99.1 Investor Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T.+1.610.832.4087 Media Contact: Melissa McClain Communications Director [email protected] T. +1.610.832.7809 For Release: Immediate Quaker Houghton Appoints Joseph Berquist as CEO and President CONSHOHOCKEN, PA (November 18, 2024) /PRNewswire/ – Quaker Houghton ("the Company"; NYSE

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 14, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-1201

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 31, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdictio

QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2024 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2024 RESULTS •Q3’24 net sales of $462.3 million, net income of $32.3 million and earnings per diluted share of $1.81 •Q3’24 non-GAAP net income of $34.0 million and non-GAAP earnings per diluted share of $1.89 •De

Quaker Houghton Third Quarter 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

Quaker Houghton Third Quarter 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

Employment Agreement by and between the Registrant and T

EXHIBIT 10.1 EMPLOYMENT AGREEMENT May 6, 2024 NAME: Tom Coler The parties to this Employment Agreement (“Agreement”) are Tom Coler (“You” or the “Executive”) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (“Quaker Houghton” or the “Company”). You are hereby appointed as the Company’s EVP and Chief Financial Officer (“CFO”) effective June 10, 2024. NOW THEREFORE

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2024 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2024 RESULTS •Q2’24 net sales of $463.6 million, net income of $34.9 million and earnings per diluted share of $1.94 •Q2’24 non-GAAP net income of $38.2 million and non-GAAP earnings per diluted share of $2.13 •D

Quaker Houghton Second Quarter 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

Quaker Houghton Second Quarter 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

Form of Change of Control Agreement by and between the Registrant and certain executive officers (including T

EXHBIIT 10.2 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated June 10, 2024 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and Tom Coler (the “Manager”), W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its subsi

Form of Performance Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2016 Long-Term Performance Incentive Plan.*†

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUA

Form of Restricted Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2024 Long-Term Performance Incentive Plan.*†

Exhibit 10.5 RESTRICTED STOCK UNIT AWARD The Compensation and Human Resources Committee (the “Committee”) of the Board of Directors of Quaker Houghton (the “Company”) has approved the award (the “Award”) to ###PARTICIPANTNAME### (the “Grantee”), of ###TOTALAWARDS### Restricted Stock Units (“RSUs”) under the Quaker Houghton Long-Term Performance Incentive Plan (the “2024 Plan”). Each vested RSU ent

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 5, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction

Form of Restricted Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2024 Long-Term Performance Incentive Plan.*†

Exhibit 10.4 RESTRICTED STOCK UNIT AWARD Pursuant to the current compensation structure at Quaker Houghton (the “Company”) for a member of the Board of Directors of the Company (the “Board”), ###PARTICIPANTNAME### (the “Grantee”), is hereby issued ###TOTALAWARDS### restricted stock units (“RSUs”) of the Company as a Restricted Stock Unit Award (the “Award”) under the Quaker Houghton Long-Term Perf

Form of Performance Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2024 Long-Term Performance Incentive Plan.*†

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 31, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction o

Quaker Houghton Appoints Two New Independent Directors to its Board of Directors

Exhibit 99.1 NEWS Investor Relations Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 Media Contact: Nicole Mezlo Communications Lead [email protected] T. 1.202.213.2490 For Release: Immediate Quaker Houghton Appoints Two New Independent Directors to its Board of Directors CONSHOHOCKEN, PA (PR Newswire) – July 31, 2024 – Quaker Hought

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 A. Full title of the plan and the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT QUAKER CHEMICAL CORPORATION (Exact Name of Registrant as Specified in Its Charter) Pennsylvania 23-0993790 (State or Other Jurisdiction of I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT QUAKER CHEMICAL CORPORATION (Exact Name of Registrant as Specified in Its Charter) Pennsylvania 23-0993790 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) One Quaker Park, 901 E. Hector Street Conshohocken, Pennsylvania 19428-2380 (Addres

Conflict Minerals Report of Quaker Chemical Corporation for the period of January 1, 2023 to December 31, 2023, as required by Items 1.01 and 1.02 of this Form.

Conflict Minerals Report of Quaker Chemical Corporation for the period of January 1, 2023 to December 31, 2023 1.

Fifth Amended and Restated Supplemental Confirmation No. 2, dated May 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

Exhibit 99.1 Execution Version FIFTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The p

Supplemental Confirmation No. 8, dated May 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

Exhibit 99.8 Execution Version SUPPLEMENTAL CONFIRMATION NO. 8 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The purpose of this Supplemental

KWR / Quaker Chemical Corporation / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm2415489d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 18)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Li

Fifth Amended and Restated Supplemental Confirmation No. 1, dated May 22, 2024, by and among QH Hungary Holdings Limited and Royal Bank of Canada.

Exhibit 99.6 Execution Version FIFTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this F

Second Amended and Restated Supplemental Confirmation No. 7, dated May 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

Exhibit 99.5 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 7 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Reference Number:             To be advised. The purpose of

Supplemental Confirmation No. 5, dated May 22, 2024, by and among QH Hungary Holdings Limited and Royal Bank of Canada.

Exhibit 99.9 Execution Version SUPPLEMENTAL CONFIRMATION NO. 5 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number:             To be advised. The purpose of this Supplemental Con

Second Amended and Restated Supplemental Confirmation No. 3, dated May 22, 2024, by and among QH Hungary Holdings Limited and Royal Bank of Canada.

Exhibit 99.7 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 3 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this

Second Amended and Restated Supplemental Confirmation No. 6, dated May 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

Exhibit 99.4   Execution Version   SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 6   Date: May 22, 2024     To: QH Hungary Holdings Limited   BAH Center | 2 Furj street, Building B, Ground fl.   1124 Budapest, Hungary   Attn: Balazs Horvath Dr   T: +36 1 646 4638   Email: [email protected], [email protected]         From: Citibank, N.A.   Reference Number:      To be

Second Amended and Restated Supplemental Confirmation No. 3, dated May 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

Exhibit 99.2 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 3 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The

Second Amended and Restated Supplemental Confirmation No. 5, dated May 22, 2024, by and among QH Hungary Holdings Limited and Citibank, N.A.

Exhibit 99.3 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 5 Date: May 22, 2024 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From:  Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The

As filed with the Securities and Exchange Commission on May 14, 2024

As filed with the Securities and Exchange Commission on May 14, 2024 Registration No.

Filing Fee Table.

Exhibit 107.1 Calculation of Filing Fee Table Form S-8 (Form Type) Quaker Chemical Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $1

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 8, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Quaker Chemical Corporation 2024 Long-Term Incentive Plan. Incorporated by reference to Exhibit 10.1 as filed by the Registrant within its current report on Form 8-K on May 9, 2024

QUAKER HOUGHTON LONG-TERM PERFORMANCE INCENTIVE PLAN (AMENDED AND RESTATED EFFECTIVE FEBRUARY 28, 2024) TABLE OF CONTENTS PAGE 1.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 6, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Quaker Houghton Announces CFO Transition

Exhibit 99.1 News Investor Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T.+1.610.832.4087 Media Contact: Nicole Mezlo Communications Lead [email protected] T. +1.202.213.2490 For Release: Immediate Quaker Houghton Announces CFO Transition CONSHOHOCKEN, PA (May 9, 2024) /PRNewswire/ – Quaker Houghton ("the Company"; NYSE: KWR) announced today that i

Quaker Houghton First Quarter 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

Quaker Houghton First Quarter 2024 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2024 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2024 RESULTS •Q1’24 net sales of $469.8 million, net income of $35.2 million and earnings per diluted share of $1.95 •Q1’24 non-GAAP net income of $37.7 million and non-GAAP earnings per diluted share of $2.09 •De

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 2, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Subsidiaries and Affiliates of the Registrant.*

EXHIBIT 21 SUBSIDIARIES AND AFFILIATES OF THE REGISTRANT Name Jurisdiction of Incorporation Percentage of Voting Securities Owned Directly or Indirectly by Quaker * Quaker Houghton Argentina S.

QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS •Q4’23 net sales of $467.1 million, net income of $20.2 million and earnings per diluted share of $1.12 •Q4’23 non-GAAP net income of $31.9 million and non-GAAP earnings per diluted sha

Quaker Houghton Fourth Quarter and Full Year 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an an

Quaker Houghton Fourth Quarter and Full Year 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 29, 2024 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

Quaker Houghton Compensation Recoupment Policy

Exhibit 97 QUAKER HOUGHTON COMPENSATION RECOUPMENT POLICY Adopted September 20, 2023 Policy The Board of Directors (the “Board”) of Quaker Houghton has adopted this Compensation Recoupment Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities and Exchange Act of 1934, the Securities and Exchange Commission (“SEC”) regulations promulgated thereunder, and applicable New York Stock Exchange (“NYSE”) listing standards.

Memorandum of Employment by and between the Registrant and Jeffrey Kutz dated November 30, 2023 and effective January 2, 2024

EXHIBIT 10.14 November 20, 2023 Jeff Kutz [REDACTED] Dear Jeff: Congratulations! I am pleased to offer you the opportunity to join Quaker Houghton in the position of VP, Chief Accounting Officer located in Conshohocken, PA. Your tentative start date is January 2, 2024. At Quaker Houghton, we make the essentials of everyday life possible and enable new approaches for a positive future. Based in eve

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER C

KWR / Quaker Chemical Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Quaker Chemical Corp Title of Class of Securities: Common Stock CUSIP Number: 747316107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

KWR / Quaker Chemical Corporation / Durable Capital Partners LP - AMENDMENT TO SC 13G Passive Investment

SC 13G/A 1 quakersc13ga-123123.htm AMENDMENT TO SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Quaker Chemical Corporation (Name of Issuer) Common Stock, $1 par value (Title of Class of Securities) 747316107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statem

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 30, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

KWR / Quaker Houghton / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 17)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

Second Amended and Restated Supplemental Confirmation No. 1, dated November 22, 2023, by and among QH Hungary Holdings Limited and Citibank, N.A.

EX-99.1 2 tm2331550d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1 Date: November 22, 2023 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-1201

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 2, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdictio

Quaker Houghton Third Quarter 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

Quaker Houghton Third Quarter 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2023 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2023 RESULTS •Q3’23 net sales of $490.6 million, net income of $33.7 million and earnings per diluted share of $1.87 •Q3’23 non-GAAP net income of $36.9 million and non-GAAP earnings per diluted share of $2.05 •De

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 5, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 3, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or

Filing Fee Table

Exhibit 107 Filing Fee Table Title of each class of securities to be registered(1) Amount to be registered(2) Proposed maximum offering price per unit(3) Proposed maximum aggregate offering price Fee Rate Amount of registration fee prior to offset Common Stock, $1.

As filed with the Securities and Exchange Commission on August 3, 2023

As filed with the Securities and Exchange Commission on August 3, 2023 Registration No.

As filed with the Securities and Exchange Commission on August 3, 2023

As filed with the Securities and Exchange Commission on August 3, 2023 Registration No.

EXPLANATORY NOTE

Table of Contents EXHIBIT 99.1 EXPLANATORY NOTE As previously disclosed, during the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. Prior to the Company’s reorganization, the Compan

Filing Fee Table.

Exhibit 107 Filing Fee Table Title of each class of securities to be registered(1) Amount to be registered(2) Proposed maximum offering price per unit(3) Proposed maximum aggregate offering price Fee Rate Amount of registration fee prior to offset Common Stock, $1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 3, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL COR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 3, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction

Employment Agreement by and between the Registrant and Anna Ransley dated July 31, 2023, effective July 31,2023. Incorporated by reference to Exhibit 10.1 as filed by the Registrant with Form 10-Q for the quarter ended June 30, 2023.†

EXHIBIT 10.1 EMPLOYMENT AGREEMENT NAME: ANNA RANSLEY [REDACTED] July 31, 2023 The parties to this Employment Agreement (“Agreement”) are Anna Ransley (“You” or the “Executive”) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (“Quaker Houghton” or the “Company”). You are hereby appointed as the Company’s SVP and Chief Digital Information Officer (“CDIO”). NOW THER

Form of Change of Control Agreement by and between the Registrant and certain executive officers (including Anna Ransley). Incorporated by reference to Exhibit 10.2 as filed by the Registrant with Form 10-Q for the quarter ended June 30, 2023.†

Exhibit 10.2 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated July 31, 2023 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”) and ANNA RANSLEY (the “Manager”), W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its su

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUA

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 1, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2023 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2023 RESULTS •Net sales of $495.4 million in Q2’23, an increase of 1% compared to Q2’22 driven by value-based pricing initiatives •Q2’23 net income of $29.3 million and earnings per diluted share of $1.63 •Q2’23

Quaker Houghton Second Quarter 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

kwr2023q2ex-992 Quaker Houghton Second Quarter 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction o

Quaker Houghton Appoints Russell R. Shaller to its Board Of Directors

Exhibit 99.1 NEWS Investor Relations Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 Media Contact: Melissa McClain Director, Communications [email protected] T. 1.610.832.7809 For Release: Immediate Quaker Houghton Appoints Russell R. Shaller to its Board Of Directors CONSHOHOCKEN, PA (PR Newswire) – July 26, 2023 – Quaker Houghton

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 A. Full title of the plan and the

EX-1.01

Conflict Minerals Report of Quaker Chemicals Corporation for the period of January 1, 2022 to December 31, 2022 1.

As filed with the Securities and Exchange Commission on May 24, 2023

As filed with the Securities and Exchange Commission on May 24, 2023 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2023

As filed with the Securities and Exchange Commission on May 24, 2023 Registration No.

Filing Fee Table.

Exhibit 107 CALCULATION OF REGISTRATION FEE FORM S-8 (Form Type) Quaker Chemical Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit(1) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 10, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 10, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Quaker Houghton First Quarter 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this

kwr2023q1ex-992 Quaker Houghton First Quarter 2023 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2023 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2023 RESULTS •Record net sales of $500.1 million in Q1’23, an increase of 5% compared to Q1’22 driven by value-based pricing initiatives •Q1’23 net income of $29.5 million and earnings per diluted share of $1.64 •

Form of Performance Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2016 Long-Term Performance Incentive Plan. Incorporated by reference to Exhibit 10.3 as filed by the Registrant with Form 10-Q for the quarter ended on March 31, 2023.†

EXHIBIT 10.3 PERFORMANCE STOCK UNIT AWARD The Compensation and Human Resources Committee (the “Committee”) of the Board of Directors of Quaker Houghton has approved the award (the “Award”) to [PARTICIPANT NAME] (the “Grantee”), of [TOTAL AWARD] performance stock units (PSUs) as of [GRANT DATE] (the “Grant Date”), subject to achieving a pre-determined targeted performance based on the Company’s adj

Form of Change of Control Agreement by and between the Registrant and certain executive officers (including Jeffrey Fleck). Incorporated by reference to Exhibit 10.2 as filed by the Registrant with Form 10-Q for the quarter ended March 31, 2023.†

EXHIBIT 10.2 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated JANUARY 23, 2023 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”), and Jeff Fleck (the “Manager”), W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QU

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 4, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdiction of

Employment Agreement by and between the Registrant and Jeffrey Fleck dated January 23, 2023, effective February 27, 2023. Incorporated by reference to Exhibit 10.1 as filed by the Registrant with Form 10-Q for the quarter ended March 31, 2023.†

EXHIBIT 10.1 EMPLOYMENT AGREEMENT January 23, 2023 NAME: Jeff Fleck [ REDACTED ] The parties to this Employment Agreement (“Agreement”) are Jeff Fleck (“You” or the “Executive”) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (“Quaker Houghton” or the “Company”). You are hereby appointed as the Company’s Senior Vice President, Chief Global Supply Chain Officer (“

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2

Exhibit 99.4 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2 Date: March 6, 2023 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this

FOURTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2

Exhibit 99.1 Execution Version FOURTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2 Date: March 6, 2023 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The

FOURTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1

Exhibit 99.3 Execution Version FOURTH AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1 Date: March 6, 2023 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this

SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 4

Exhibit 99.2 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 4 Date: March 6, 2023 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The

KWR / Quaker Houghton / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

SC 13D/A 1 tm238929d3sc13daseq1.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 16)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings

SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 4

Exhibit 99.5 Execution Version SECOND AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 4 Date: March 6, 2023 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this

QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Vice President, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS •Q4’22 net sales of $484.8 million increased 8% compared to Q4’21 driven by higher selling prices •Record full year 2022 net sales of $1.9 billion primarily driven by value-based pricin

Subsidiaries and Affiliates of the Registrant.*

EXHIBIT 21 SUBSIDIARIES AND AFFILIATES OF THE REGISTRANT Name Jurisdiction of Incorporation Percentage of Voting Securities Owned Directly or Indirectly by Quaker * Quaker Houghton Argentina S.

Quaker Houghton Fourth Quarter and Full Year 2022 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an an

earningscallpresentation Quaker Houghton Fourth Quarter and Full Year 2022 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 23, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 23, 2023 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania 23-0993790 (State or other jurisdicti

KWR / Quaker Chemical Corp / Durable Capital Partners LP - AMENDMENT TO FORM SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Quaker Chemical Corporation (Name of Issuer) Common Stock, $1 par value (Title of Class of Securities) 747316107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

KWR / Quaker Chemical Corp / Neuberger Berman Group LLC - NONE Passive Investment

SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* QUAKER CHEMICAL CORP (Name of Issuer) Common (Title of Class of Securities) 747316107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

KWR / Quaker Chemical Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01739-quakerchemicalcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Quaker Chemical Corp. Title of Class of Securities: Common Stock CUSIP Number: 747316107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to de

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 19, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisd

Amended and Restated By-laws (effective December 19, 2022). Incorporated by reference to Exhibit 3.1 as filed by the Registrant within its current report on Form 8-K on December 20, 2022.

Exhibit 3.1 QUAKER CHEMICAL CORPORATION (a Pennsylvania Corporation) AMENDED AND RESTATED BY-LAWS (as of December 19, 2022) Section 1.1. Registered Office The Registered Office of the Corporation shall be at 901 Hector Street, Conshohocken, Pennsylvania until otherwise changed by the Board of Directors. Section 2.1. Place or Means of Shareholders' Meetings Meetings of the shareholders shall be hel

Quaker Houghton Third Quarter 2022 Results Investor Conference Call

Exhibit 99.2 Quaker Houghton Third Quarter 2022 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (?GAAP?). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and helps investors

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 3, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdi

QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2022 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Senior Director, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2022 RESULTS ? Net sales of $492.2 million increased 10% compared to Q3?21 driven by higher selling prices ? Reported net income of $25.9 million and earnings per diluted share of $1.44 ? Non-GAAP net income of $

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 17, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdi

THIRD AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2

Exhibit 99.2 Execution Version THIRD AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 2 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. Th

AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 3

Exhibit 99.3 Execution Version AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 3 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The purp

ISDA® International Swaps and Derivatives Association, Inc. NOVATION AGREEMENT dated as of August 10, 2022 among: QH Hungary Holdings Limited (the "Remaining Party"), JPMorgan Chase Bank, National Association (the "Transferor") Citibank, N.A. (the "T

Exhibit 99.5 Execution Version ISDA? International Swaps and Derivatives Association, Inc. NOVATION AGREEMENT dated as of August 10, 2022 among: QH Hungary Holdings Limited (the "Remaining Party"), JPMorgan Chase Bank, National Association (the "Transferor") AND Citibank, N.A. (the "Transferee"). The Transferor and the Remaining Party have entered into two Transactions as identified in the attache

THIRD AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1

Exhibit 99.8 Execution Version THIRD AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of thi

AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 7

Exhibit 99.7 Execution Version AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 7 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Reference Number: To be advised. The purpose of this Amended an

AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 6

Exhibit 99.6 Execution Version AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 6 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Reference Number: To be advised. The purpose of this Amended an

AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 5

Exhibit 99.4 Execution Version AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 5 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A Fax No.: 212-615-8985 Reference Number: To be advised. The purpo

SHARE PurchAse and Sale agreement

Exhibit 99.1 Execution Version SHARE PurchAse and Sale agreement THIS SHARE PURCHASE AND SALE AGREEMENT (this ?Agreement?) is made as of August 10, 2022, by and between Citigroup Global Markets Inc. (?Seller?) and QH Hungary Holdings Limited (?Buyer?). Seller and Buyer are sometimes referred to in this Agreement together as the ?Parties? or individually as a ?Party?. Background A. Seller desires t

AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 3

Exhibit 99.9 Execution Version AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 3 Date: August 10, 2022 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this Amen

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 15)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 14)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

Quaker Houghton Second Quarter 2022 Results Investor Conference Call

EX-99.2 3 tm2222545d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Quaker Houghton Second Quarter 2022 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operat

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 4, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdict

Memorandum of Employment by and between the Registrant and Melissa Leneis dated May 24, 2022 and effective July 5, 2022. Incorporated by reference to Exhibit 10.2 as filed by the Registrant with Form 10-Q for the quarter ended June 30, 2022.†

EXHIBIT 10.2 1 EMPLOYMENT AGREEMENT May 24, 2022 NAME: Melissa Leneis [ REDACTED ] The parties to this Employment Agreement (?Agreement?) are Melissa Leneis (?You? or the ?Executive?) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (?Quaker Houghton? or the ?Company?). You are hereby appointed as the Company?s Senior Vice President and Chief Human Resources Offic

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2022 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Senior Director, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2022 RESULTS ? Record net sales of $492.4 million increased 13% compared to Q2?21 driven by higher selling prices ? Reported net income of $14.3 million and earnings per diluted share of $0.80 ? Delivered $58.5

Memorandum of Employment by and between the Registrant and Dhruwa Rai dated June 23, 2022 and effective July 6, 2022. Incorporated by reference to Exhibit 10.4 as filed by the Registrant with Form 10-Q for the quarter ended June 30, 2022.†

EXHIBIT 10.4 1 EMPLOYMENT AGREEMENT June 23, 2022 NAME: Dhruwa Rai [ REDACTED ] The parties to this Employment Agreement (?Agreement?) are Dhruwa Rai (?You? or the ?Executive?) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (?Quaker Houghton? or the ?Company?). You are hereby appointed as the Company?s Senior Vice President and Chief Information and Digital Offi

Form of Change of Control Agreement by and between the Registrant and certain executive officers (including Melissa Leneis). Incorporated by reference to Exhibit 10.3 as filed by the Registrant with Form 10-Q for the quarter ended June 30, 2022.†

1 EXHIBIT 10.3 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated May 24, 2022 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the ?Company?), and MELISSA LENEIS (the ?Manager?), W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and it

Form of Change of Control Agreement by and between the Registrant and certain executive officers (including

1 EXHIBIT 10.5 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated June 23, 2022 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the ?Company?), and DHRUWA RAI (the ?Manager?), W I T N E S S E T H T H A T WHEREAS, the Board of Directors of the Company has determined that it is in the best interests of the Company and its shareholders that the Company and its s

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORPO

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 12)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 11)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budape

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budapes

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budapes

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korlátolt Felelősségű Társaság and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budapes

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 11-K [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 A. Full title of the plan and the

Amendment No. 3, dated as of June 17, 2022, to the Credit Agreement, dated as of August 1, 2019, as amended. Incorporated by reference to Exhibit 10.1 as filed by the Registrant with Form 8-K filed on June 21, 2022.

Exhibit 10.1 AMENDMENT NO. 3 TO CREDIT AGREEMENT THIS AMENDMENT NO. 3 TO CREDIT AGREEMENT (this ?Amendment?) is made and entered into as of June 17, 2022 by and among QUAKER CHEMICAL CORPORATION, a Pennsylvania corporation (the ?Company?), certain Subsidiaries of the Company party hereto (each a ?Designated Borrower? and, together with the Company, the ?Borrowers? and, each a ?Borrower?), each gua

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 17, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdicti

KWR / Quaker Chemical Corp / Gulf Hungary Holding Korlatolt Felelossegu Tarsasag - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Quaker Chemical Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 747316107 (CUSIP Number) Gulf Hungary Holding Korl?tolt Felel?ss?g? T?rsas?g and QH Hungary Holdings Limited BAH Center 2 Furj Street 1124 Budapes

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 11, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdictio

Quaker Houghton First Quarter 2022 Results Investor Conference Call

EX-99.2 3 tm2214563d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Quaker Houghton First Quarter 2022 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operati

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 5, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdiction

QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2022 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Senior Director, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2022 RESULTS ? Record net sales of $474.2 million increased 10% compared to 1Q21 driven by higher selling prices ? Reported net income of $19.8 million and earnings per diluted share of $1.11 ? Delivered $60.4 mi

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14

Quaker Houghton Annual Incentive Plan (as amended and restated effective November 17, 2021). *†

1 EXHIBIT 10.27 QUAKER HOUGHTON ANNUAL INCENTIVE PLAN (As Amended and Restated Effective November 17, 2021) WHEREAS , Quaker Chemical Corporation (the ?Company?) established the Quaker Chemical Corporation Global Annual Incentive Plan (the ?Prior Plan?); and WHEREAS , the Company desires to amend and restate the Prior Plan as the Quaker Houghton Annual Incentive Plan (the ?Plan?) to update the Pla

Retirement Savings Plan, as amended and restated effective January 22, 2021, approved November 1, 2021. *†

1 EXHIBIT 10.26 QUAKER HOUGHTON RETIREMENT SAVINGS PLAN (As Amended and Restated Effective January 1, 2021) 1 ARTICLE I DEFINITIONS .......................................................................................................... 1 1.1 ?AC Participant? .................................................................................................... 1 1.2 ?AC Products Discretionary Cont

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORPORATIO

Amendment No. 2, dated as of December 10, 2021, to the Credit Agreement, dated as of August 1, 2019.

1 EXHIBIT 10.46 Execution Version AMENDMENT NO. 2 TO CREDIT AGREEMENT (LIBOR TRANSITION) THIS AMENDMENT NO. 2 TO CREDIT AGREEMENT (LIBOR TRANSITION) (this ?Agreement?) is made and entered into as of December 10, 2021 by and among QUAKER CHEMICAL CORPORATION , a Pennsylvania corporation (the ?Company?) and BANK OF AMERICA, N.A. , as Administrative Agent (in such capacity, the ?Administrative Agent?

Subsidiaries and Affiliates of the Registrant.*

1 EXHIBIT 21 SUBSIDIARIES AND AFFILIATES OF THE REGISTRANT Jurisdiction of Percentage of Voting Securities Owned Name Incorporation Directly or Indirectly by Quaker * Quaker Chemical, S.

QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS

Exhibit 99.1 NEWS Contact: Jeffrey Schnell Senior Director, Investor Relations [email protected] T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS ? Fourth quarter net sales of $447.0 million increased 16% compared to the fourth quarter of 2020, driving record full year net sales of $1,761.2 million for 2021 ? Fourth quarter and

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 24, 2022 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisd

Quaker Houghton Fourth Quarter and Full Year 2021 Results Investor Conference Call

Exhibit 99.2 Quaker Houghton Fourth Quarter and Full Year 2021 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles ("GAAP"). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and

KWR / Quaker Chemical Corp / Neuberger Berman Group LLC - NONE Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* QUAKER CHEMICAL CORP (Name of Issuer) Common (Title of Class of Securities) 747316107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

KWR / Quaker Chemical Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Quaker Chemical Corp. Title of Class of Securities: Common Stock CUSIP Number: 747316107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed

KWR / Quaker Chemical Corp / Durable Capital Partners LP - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Quaker Chemical Corporation (Name of Issuer) Common Stock, $1 par value (Title of Class of Securities) 747316107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th

QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2021 RESULTS

Exhibit 99.1 NEWS Contact: Shane W. Hostetter Senior Vice President and Chief Financial Officer [email protected] T. 1.610.832.4000 For Release: Immediate QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2021 RESULTS ? Record net sales of $449.1 million increased 22% compared to the third quarter of 2020 ? Reported net income of $31.1 million, earnings per diluted share of $1.73 and non-GAAP net

Change in Control Agreement by and between Registrant and Andrew Tometich dated September 2, 2021, effective on October 11, 2021. Incorporated by reference to Exhibit 10.2 as filed by the Registrant with Form 10-Q for the quarter ended on September 30, 2021.†

1 EXHIBIT 10.2 CHANGE IN CONTROL AGREEMENT THIS AGREEMENT, dated September 2, 2021 between QUAKER CHEMICAL CORPORATION, d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the ?Company?), and Andrew Tometich (the ?Executive?). W I T N E S S E T H T H A T WHEREAS, the Executive and the Company entered into an employment agreement dated September 2, 2021; and WHEREAS, the Executive and the Company wi

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL

Quaker Houghton Third Quarter 2021 Results Investor Conference Call

Exhibit 99.2 Quaker Houghton Third Quarter 2021 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (?GAAP?). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and helps investors

Employment Agreement by and between Registrant and Joseph Berquist dated August 18 2021, effective on September 9, 2021. Incorporated by reference to Exhibit 10.3 as filed by the registrant with Form 10-Q for the quarter ended September 30, 2021.†

EXHIBIT 10.3 1 August 18, 2021 Joe Berquist Quaker Houghton Dear Joe: Congratulations! I am pleased to offer you this promotion to the EVP, Chief Strategy Officer and MD, Global Specialty Businesses. In addition to your current responsibilities for directing the Company?s strategic priorities and leading the Global Specialty Business segment, you will be responsible for directing the Company?s glo

Employment Agreement by and between Registrant and Andrew Tometich dated September 2, 2021, effective on October 11, 2021. Incorporated by reference to Exhibit 10.1 as filed by the Registrant with Form 10-Q for the quarter ended September 30, 2021.†

EXHIBIT 10.1 1 EMPLOYMENT AGREEMENT September 2, 2021 NAME: Andrew Tometich [ REDACTED ] [ REDACTED ] The parties to this Employment Agreement (?Agreement?) are Andrew Tometich (?You? or the ?Executive?) and Quaker Chemical Corporation, d/b/a Quaker Houghton, a Pennsylvania corporation (?Quaker Houghton? or the ?Company?). You are hereby appointed as the Company?s Chief Executive Officer and Presi

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 4, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 2, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisd

Quaker Houghton Appoints Andrew Tometich as Chief Executive Officer

Exhibit 99.1 NEWS Investor Contact: Shane Hostetter Senior Vice President, Chief Financial Officer [email protected] T. 1.610.832.4000 Media Contact: Melissa McClain Director, Global Communications [email protected] T. 1.610.832.7809 For Release: Immediate Quaker Houghton Appoints Andrew Tometich as Chief Executive Officer CONSHOHOCKEN, PA (PR Newswire) ? September 8, 2021 ? Quake

Form of Performance Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2016 Long-Term Performance Incentive Plan. Incorporated by reference to Exhibit 10.6 as filed by the Registrant with Form 10-Q for the quarter ended on June 30, 2021.†

1 EXHIBIT 10.6 PERFORMANCE STOCK UNIT AWARD The Compensation and Human Resources Committee (the ?Committee?) of the Board of Directors of Quaker Houghton has approved the award (the ?Award?) to FIRST NAME LAST NAME (the ?Grantee?) , of XXX performance stock units (PSUs) as of MM DD, YEAR (the ?Grant Date?), subject to achieving a pre-determined targeted performance based on the Company?s relative

Form of Incentive Stock Option Award Agreement for executive officers and other employees under Registrant’s 2016

1 Exhibit 10.3 INCENTIVE STOCK OPTION AWARD An Incentive Stock Option (the ?Option?) for a total of XXX shares of $1.00 par value per share Common Stock (the ?Stock?) of Quaker Chemical Corporation, also known as Quaker Houghton, a Pennsylvania corporation (the ?Company?), is hereby granted as of MM DD, YEAR (the ?Grant Date?) to First Name Last Name (the ?Optionee?), subject to the terms and prov

Form of Restricted Stock Unit Award Agreement for executive officers and other employees under Registrant’s 2016

1 EXHIBIT 10.5 RESTRICTED STOCK UNIT AWARD The Compensation and Human Resources Committee (the ?Committee?) of the Board of Directors of Quaker Houghton (?the Company?) has approved the award (the ?Award?) to First Name Last Name (?the Grantee?), of XX Restricted Stock Units (?RSUs?) under the Quaker Houghton 2016 Long-Term Performance Incentive Plan (the ?Plan?). Each vested RSU entitles Grantee

Form of Restricted Stock Award Agreement for non-employee directors under Registrant’s 2016 Long-Term

1 EXHIBIT 10.1 RESTRICTED STOCK AWARD Pursuant to the current compensation structure for a member of the Board of Directors of Quaker Houghton (the ?Board?), First Name Last Name (the ?Grantee?), is hereby issued shares of $1.00 par value Common Stock of Quaker Houghton (the ?Company?) as a Restricted Stock Award (the ?Award?) under the Quaker Houghton 2016 Long-Term Performance Incentive Plan (th

Form of Non-Qualified Stock Option Award Agreement for executive officers and other employees under Registrant’s

1 EXHIBIT 10.4 NON-QUALIFIED STOCK OPTION AWARD A Non-Qualified Stock Option (the ?Option?) for a total of XXX shares of $1.00 par value per share Common Stock (the ?Stock?) of Quaker Chemical Corporation, also known as Quaker Houghton, a Pennsylvania corporation (the ?Company?), is hereby granted as of MM DD, YEAR (the ?Grant Date?) to First Name Last Name (the ?Optionee?), subject to the terms a

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORPO

Form of Restricted Stock Award Agreement for executive officers and other employees under Registrant’s 2016 Long- Term Performance Incentive Plan. Incorporated by reference to Exhibit 10.2 as filed by the Registrant with Form 10- Q for the quarter ended on June 30, 2021. †

1 EXHIBIT 10.2 RESTRICTED STOCK AWARD The Compensation and Human Resources Committee (the ?Committee?) of the Board of Directors of Quaker Houghton (?the Company?) has approved the award (the ?Award?) to First Name Last Name (the ?Grantee?), of XXX shares of $1.00 par value Common Stock of the Company as a Restricted Stock Award under the Quaker Houghton 2016 Long -Term Performance Incentive Plan

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2021 RESULTS

Exhibit 99.1 NEWS Contact: Shane W. Hostetter Senior Vice President and Chief Financial Officer [email protected] T. 1.610.832.4000 For Release: Immediate QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2021 RESULTS ? Record net sales of $435.3 million increased 52% compared to the second quarter of 2020 and up 1% sequentially compared to the first quarter of 2021 ? Gross margin of 35.5% improv

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 3, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdict

Quaker Houghton Second Quarter 2021 Results Investor Conference Call

Exhibit 99.2 Quaker Houghton Second Quarter 2021 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (?GAAP?). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and allows investo

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 11-K [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 A. Full title of the plan and the

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 12, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 PENNSYLVANIA No. 23-0993790 (State or other jurisdictio

Memorandum of Employment by and between the Registrant and Shane Hostetter dated and effective April 19, 2021. Incorporated by reference to Exhibit 10.1 as filed by the Registrant with Form 10-Q for the quarter ended on March 31, 2021.†

1 EXHIBIT 10.1 MEMORANDUM OF EMPLOYMENT April 19, 2021 Shane W. Hostetter [ Redacted ] The parties to this Memorandum of Employment (?Agreement?) are Shane W. Hostetter and Quaker Chemical Corporation , a Pennsylvania corporation, doing business as Quaker Houghton (?Quaker Houghton? or the ?Company?). You are appointed Quaker Houghton?s Senior Vice President and Chief Financial Officer effective a

QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2021 RESULTS

Exhibit 99.1 NEWS Contact: Shane W. Hostetter Senior Vice President and Chief Financial Officer [email protected] T. 1.610.832.4000 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2021 RESULTS ? Strong earnings driven by continued recovery in the Company?s end-markets and customer demand and the continued execution of integration activities and synergy realization ? Net sa

Quaker Houghton First Quarter 2021 Results Investor Conference Call

Exhibit 99.2 Quaker Houghton First Quarter 2021 Results Investor Conference Call Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (?GAAP?). Man agement believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and allows investor

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 6, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdiction

April 19, 2021. Incorporated by reference to Exhibit 10.3 as filed by the Registrant with Form 10-Q for the quarter

1 EXHIBIT 10.3 March 22, 2021 David Will Quaker Houghton Dear David: Congratulations! I am pleased to offer you this promotion with Quaker Houghton as VP, Global Controller. Your tentative start date for this position is April 19, 2021. We believe you can make significant contributions in this role and will find this opportunity exciting and rewarding. Please review the details of the offer below.

Quarterly Report - QUAKER CHEMICAL CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORP

Chief Executive Officer Transition Agreement dated April 22, 2021, effective December 31, 2021. Incorporated by reference to Exhibit 10.4 as filed by the Registrant with Form 10-Q for the quarter ended on March 31, 2021.†

1 EXHIBIT 10.4 TRANSITION AGREEMENT This Transition Agreement (this ? Agreement ?), dated as of April 22, 2021 is made between Michael F. Barry (? Executive ?) and Quaker Chemical Corporation (? Quaker ? or the ? Company ?). WHEREAS, Executive and Quaker are parties to the Employment Agreement dated July 1, 2008 regarding Executive?s employment as the Company?s Chief Executive Officer and Presiden

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 26, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdict

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 26, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdict

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 22, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 PENNSYLVANIA No. 23-0993790 (State or other jurisdict

- DEF 14A

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 18, 2021 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number 001-12019 Pennsylvania No. 23-0993790 (State or other jurisdict

QUAKER HOUGHTON ANNOUNCES CFO TRANSITION

Exhibit 99.1 NEWS Investor Contact: Mary Dean Hall Senior Vice President, Chief Financial Officer and Treasurer [email protected] T. 1.610.832.4000 Media Contact: Melissa McClain Director, Communications [email protected] T. 1.610.832.7809 For Release: Immediate QUAKER HOUGHTON ANNOUNCES CFO TRANSITION CONSHOHOCKEN, PA (PR Newswire) – March 24, 2021 - Quaker Houghton (“the Company

SUPPLEMENTAL CONFIRMATION NO. 5

Exhibit 99.2 Execution Version SUPPLEMENTAL CONFIRMATION NO. 5 Date: March 9, 2021 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The purpose of this Supplementa

AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1

Exhibit 99.8 Execution Version AMENDED AND RESTATED SUPPLEMENTAL CONFIRMATION NO. 1 Date: March 9, 2021 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Royal Bank of Canada Reference Number: To be advised. The purpose of this Amende

SUPPLEMENTAL CONFIRMATION NO. 2

Exhibit 99.5 Execution Version SUPPLEMENTAL CONFIRMATION NO. 2 Date: March 9, 2021 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: JPMorgan Chase Bank, National Association Reference Number: To be advised. The purpose of this Supple

SUPPLEMENTAL CONFIRMATION NO. 4

Exhibit 99.1 Execution Version SUPPLEMENTAL CONFIRMATION NO. 4 Date: March 9, 2021 To: QH Hungary Holdings Limited BAH Center | 2 Furj street, Building B, Ground fl. 1124 Budapest, Hungary Attn: Balazs Horvath Dr T: +36 1 646 4638 Email: [email protected], [email protected] From: Citibank, N.A. Fax No.: 212-615-8985 Reference Number: To be advised. The purpose of this Supplementa